Vaccination profile for COVID-19 in the municipality of Jaraguá do Sul, Santa Catarina
DOI:
https://doi.org/10.33448/rsd-v11i15.37374Keywords:
Vaccine; Coronavirus; COVID-19.Abstract
Objective: To trace the epidemiological profile of individuals vaccinated in the year 2021 in the municipality of Jaraguá do Sul, SC. Methods: This is a cross-sectional study with a quantitative approach. The population was composed of individuals vaccinated against coronavirus, registered in the information system of the Health Department of the city of Jaraguá do Sul/SC, between 01/01/2021 and 31/12/2021. The variables evaluated were gender, age range, types and doses of vaccines, administration period, and neighborhoods of residence. Results/Discussion: The highest prevalence of vaccination was in females (52.2%) and the predominant age group was adults. The neighborhood with the highest vaccination coverage was Ilha da Figueira, with 17,328 people vaccinated, followed by Barra do Rio Cerro with 15,734 and Centro with 15,366. 116,451 individuals were vaccinated with the first dose until December 2021, 109,568 with the second dose, 20,738 received a booster dose, and 6,168 received a single dose. By December 2021, 80.3% of individuals had been vaccinated with the first dose, characterizing the immunity of the herd in the municipality. Conclusions: The importance of this analysis at the municipal level is fundamental in Primary Care, because it allows the application of prevention, promotion, and health education measures.
References
Brasil. (2021). Ministério da Saúde. Plano Nacional de Operacionalização. Entenda a ordem de vacinação contra a Covid-19 entre os grupos prioritários. Brasília. http://www.gov.br
Brasil. (2022). Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de vigilância epidemiológica: emergência de saúde pública de importância nacional pela doença pelo coronavírus 2019. Brasília: Ministério da Saúde, 2022. 131 il.
Brasil. (s.d.). Coronavírus Brasil. https://covid.saude.gov.br/
Cerqueira-Silva T., Katikireddi S. V., de Araujo Oliveira V., Flores-Ortiz R., Júnior J. B., Paixão E. S. et al. (2022) Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil. Nature Medicine, 838 (28), 838-843.
Cerqueira-Silva T., Andrews J., Boaventura V., Ranzani O., Oliveira A., & Paixão E. et al (2022). Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil: a test-negative, case-control study. The Lancet, 22(6), 791-801.
Couto M.T., Barbieri C. L. A., Matos C. C. (2021) Considerações sobre o impacto da covid-19 na relação indivíduo-sociedade: da hesitação vacinal ao clamor por uma vacina. Saúde e Sociedade, 30 (1), 1-11.
Corum J, Zimmer C, & Wee S -L. (2020). Coronavirus Vaccine Tracker. The New York Times. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
Costa J. A., Silveira J. A., Santos S. C. M., & Nogueira P. P. (2020). Implicações Cardiovasculares em Pacientes Infectados com Covid-19 e a Importância do Isolamento Social para Reduzir a Disseminação da Doença. Arq. Bras. Cardiologia, 114 (5), 834-838.
Freire, M .C. M., & Pattussi M. P. Tipos de estudos. IN: Estrela, C. Metodologia científica. Ciência, ensino e pesquisa. (3ª ed.) Artes Médicas, 2018. p.109-127.
Guan, W., Liang, W., Zhao, Y., Liang, H., Chen, Z., Li, Y. et al (2020). Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. European Respiratory Journal, 55(5), 2000547.
IBGE. (s.d.). IBGE Cidades. https://cidades.ibge.gov.br/brasil/sc/panorama
Kfouri, R. (2021). Guia Prático de Atualização. Vacinas COVID-19. Departamento Científico de Imunizações, Sociedade Brasileira de Pediatria, nº12, 27 de Janeiro de 2021.
Lima-Costa M. F., Macinko J., & Mambrini J. V. M. (2022). Hesitação vacinal contra a COVID-19 em amostra nacional de idosos brasileiros. Epidemiologia e Serviços de Saúde, 31(1), 1-10.
OPAS. (2022). Vacinas contra Covid-19. https://www.paho.org/pt/vacinas-contra-covid-19.
Our World In Data. (2021). Vacinas contra o coronavírus – Covid-19. https://ourworldindata.org/covid-vaccinations?country=BRA
Our World In Data. (s.d.). Vacinação contra Covid-19, Brasil. https://coronavirusbra1.github.io/
Our World In Data. (s.d.). Coronavirus Pandemic (COVID-19). https://ourworldindata.org/coronavirus
Prefeitura de Jaraguá do Sul. (s.d.). Serviços de Saúde. Disponível em: https://www.jaraguadosul.sc.gov.br/prefeitura-nome-dos-bairros
Price-Haywood E. G., Burton J., Fort D., & Seoane L. (2020). Hospitalization and Mortality among Black Patients and White Patients with Covid-19. New England Journal of Medicine 382 (26), 2534-2543.
Quintana, S.; Francisco, R.; & Duarte, G. (2021). Vacinação Covid 19, Perguntas e Respostas. SOGESP Associação de Obstetrícia e Ginecologia do Estado de São Paulo. https://www.sogesp.com.br/media/2601/sogesp_covid19_cartilha_vacinacao_completa2104.pdf.
Quan, D., Luna Wong, L., Shallal, A., Madan, R., Hamdan, A., & Ahdi, H. et al. (2021). Impact of Race and Socioeconomic Status on Outcomes in Patients Hospitalized with COVID-19. Journal of General Internal Medicine, 36 (5), 1302- 1309.
Robinson E., Jones A., Lesser I., & Daly M. (2021). International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples. Vaccine, 29, 2024-2034.
Sanyaolu A., Okorie C., Marinkovic A., Patidar R., Younis K., Desai P. et al. (2020) Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clinical Medicine, 2(8), 1169-1176.
Santa Catarina. (s.d.). Vacinômetro Santa catarina. https://www.coronavirus.sc.gov.br/vacinometro/
Wang B., Li R., Lu Z., & Huang Y (2020). Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging, 12 (7), 6049-6047.
WHO. (2019a). Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
WHO. (2019b). Covid-19 vaccines. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines.
WHO. (2022). World Health Organization. Global excess deaths associated with COVID-19 (modelled estimates). https://www.who.int/data/sets/global-excess-deaths-associated-with-covid-19-modelled-estimates
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Danielle Daga; Paula de Oliveira Santana; Adalberto Alves de Castro; Lucas Rodrigo Hermes Leal da Costa Nunes; Luciane Peter Grillo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
